Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|60|1|60-65

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.1, 2000-12, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Analysis Comparing an Anthracycline/Docetaxel Regimen to CMF in Patients with Early Stage Breast Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 473-481

Karger

Access to resources Recommend Favorite

Phase I Study of Vinorelbine and Carboplatin Combination in Patients with Taxane and Anthracycline Pretreated Advanced Breast Cancer

By  

Oncology, Vol. 62, Iss. 2, 2002-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Weekly Low-Dose Docetaxel in Advanced Hormone-Resistant Prostate Cancer Patients Previously Exposed to Chemotherapy

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 300-305

Karger

Access to resources Recommend Favorite

Weekly Administration of Gemcitabine Plus Docetaxel in Patients with Advanced Breast Cancer: A Phase 1 Study

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 175-181

Karger

Access to resources Recommend Favorite